Published in Medical Letter on the CDC and FDA, March 12th, 2006
According to a study from the United States, "In recent years, overlap in biologic and morphologic features has been identified between classic Hodgkin lymphoma and B-cell non-Hodgkin lymphoma. Nevertheless, the therapeutic approaches for these diseases remain different."
"We undertook a study of 'mediastinal gray zone lymphomas' (MGZL), with features transitional between cHL nodular sclerosis (NS) and primary mediastinal large B-cell lymphoma to better understand the morphologic and immunophenotypic spectrum of such...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.